A troubling trend is emerging in American maternity wards as more parents decline a routine newborn treatment that has helped protect infants for more than six decades.
New research published in the Journal of the American Medical Association (JAMA) found that the percentage of newborns who did not receive a recommended vitamin K injection increased from 3.1% in 2017 to 6.8% in 2025.
The findings are based on more than 5.2 million infant health records collected from hospitals and healthcare systems across all 50 states.
Researchers from Children's Hospital of Philadelphia found that babies who did not receive the injection were significantly more likely to experience bleeding during their first six months of life.
The findings are particularly concerning because newborns naturally have low vitamin K levels, leaving them vulnerable to complications that can develop without obvious warning signs.
The central concern is that a simple preventive treatment, routinely administered shortly after birth, is being declined more frequently even as evidence continues to demonstrate its protective benefits.
What the Study Found
The research examined medical records for 5,240,780 infants born between 2017 and 2025.
During that period, the proportion of newborns who did not receive vitamin K more than doubled.
The increase accelerated in the most recent year studied, climbing from 5.6% in 2024 to 6.8% in 2025.
But researchers did not simply measure how many babies missed the injection.
They also investigated whether those infants experienced more bleeding complications.
The results revealed a significant difference.
Among babies who did not receive vitamin K, researchers recorded approximately 288 bleeding events per 10,000 infants during the first six months of life.
For babies who received the injection, the rate was approximately 186 per 10,000.
After accounting for other measured factors, infants who missed the shot had a 47% higher relative risk of bleeding.
The study also found that their adjusted risk of intracranial bleeding, or bleeding inside the skull, was more than twice as high.
These findings strengthen the evidence connecting missed vitamin K injections with preventable newborn health risks.
Why Newborns Need Vitamin K
Vitamin K is an essential nutrient that allows the body to produce proteins necessary for normal blood clotting.
Without sufficient vitamin K, even relatively minor bleeding can become dangerous.
Unlike older children and adults, newborns begin life with naturally low levels of this nutrient.
Only small amounts cross the placenta during pregnancy, and breast milk contains relatively little vitamin K.
As a result, babies can develop a condition called vitamin K deficiency bleeding, commonly known as VKDB.
This disorder can cause bleeding in the digestive system, beneath the skin, around the umbilical cord, or inside the brain.
The condition is especially dangerous because internal bleeding may develop before parents notice any visible symptoms.
The Centers for Disease Control and Prevention warns that untreated bleeding can cause permanent brain damage or death.
A single vitamin K injection administered shortly after birth helps protect infants during this vulnerable period.
The Risk of Brain Bleeding
One of the most serious complications associated with vitamin K deficiency is intracranial bleeding.
The JAMA researchers found approximately 33 cases of intracranial bleeding per 10,000 infants who did not receive the injection, compared with about 13 per 10,000 among those who did.
After adjustment for measured differences between the groups, the risk was approximately 2.4 times higher among babies who missed the treatment.
Not every bleeding event examined in the study was necessarily caused by vitamin K deficiency. Nevertheless, the difference between the groups provides important evidence of the risks associated with missing the injection.
The CDC separately estimates that newborns who do not receive vitamin K are 81 times more likely to develop late vitamin K deficiency bleeding.
That condition can develop weeks or months after a seemingly healthy baby leaves the hospital.
Unlike the study's broader bleeding measurements, the CDC figure refers specifically to vitamin K deficiency bleeding.
This distinction matters because both findings describe different aspects of newborn health risk.
Why Are More Parents Declining the Injection?
Doctors interviewed say they are encountering more families who question whether the treatment is necessary.
Dr. Thomas Patterson, an Idaho pediatrician with nearly three decades of experience, described a noticeable change in parental attitudes toward newborn vitamin K administration.
He recalled one day when five of ten babies in his care left the hospital without receiving the injection.
Healthcare professionals point to several possible explanations, including medical misinformation, concerns about ingredients, and growing distrust of healthcare institutions.
Another source of confusion involves the nature of the treatment itself.
Vitamin K is not a vaccine.
It is a vitamin supplement delivered through an injection to address the naturally low vitamin K levels present at birth.
Some parents may also believe that a healthy baby does not need preventive treatment.
However, vitamin K deficiency bleeding can occur in infants who initially appear completely healthy.
The new study documented the increase in nonreceipt but did not establish exactly why individual parents declined the injection.
A Medical Practice With Decades of Evidence
Vitamin K injections have been routinely recommended for American newborns since the early 1960s.
The treatment became standard practice because it dramatically reduced the occurrence of serious vitamin K deficiency bleeding.
The American Academy of Pediatrics recommends intramuscular vitamin K for newborns, and the CDC identifies the injection as the most reliable way to prevent VKDB.
For parents concerned about interrupting early bonding, the CDC notes that administration can be delayed for up to six hours after birth to accommodate initial skin-to-skin contact.
The treatment has a long-established safety record.
Although an early study raised questions about a possible association with childhood leukemia, subsequent investigations did not confirm that connection.
Healthcare professionals encourage families to discuss specific concerns with their pediatricians rather than relying on unverified claims circulating online.
What Parents Should Know Before Delivery
Expectant parents often spend months preparing for childbirth, selecting hospitals, attending prenatal appointments, and learning about newborn care.
Understanding the purpose of vitamin K should be part of that preparation.
Parents can ask their healthcare team when the injection will be given, what it contains, and how it protects their baby.
They should also understand that visible warning signs may not appear before serious internal bleeding develops.
Symptoms that warrant urgent medical evaluation can include unexplained bruising, bleeding, unusual irritability, poor feeding, or changes in alertness.
Any concern about possible bleeding in a newborn should be evaluated promptly by a medical professional.
Protecting America's Newest Generation
The JAMA findings highlight a growing challenge for American healthcare: ensuring that families receive accurate information about preventive treatments with well-established medical benefits.
The rise in vitamin K nonreceipt is not simply a change in parental preferences.
It is associated with measurable increases in bleeding risks among some of the country's most vulnerable patients.
For healthcare providers, the findings underscore the importance of patient education, clear communication, and building trust with expectant families.
For parents, they provide another reason to ask questions and make newborn-care decisions using credible medical evidence.
Every newborn deserves the strongest possible start in life. A routine vitamin K injection cannot prevent every medical complication, but decades of research show that it can protect babies from a dangerous and largely preventable cause of bleeding. As more families reconsider established newborn treatments, understanding the evidence may be one of the most important steps parents can take to protect their children.








